ESPERION THERAPEUTICS INC. - COMMON STOCK

Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023

11 11 2023 10:00:00 提供 Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

09 11 2023 15:30:00 提供 Nasdaq GlobeNewswire

Esperion Reports Third Quarter 2023 Financial Results

07 11 2023 05:00:00 提供 Nasdaq GlobeNewswire

Esperion to Participate in Jefferies London Healthcare Conference

31 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

Esperion to Report Third Quarter 2023 Financial Results on November 7

24 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

12 10 2023 08:52:25 提供 NetDania Notify

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

11 10 2023 10:58:14 提供 NetDania Notify

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

10 10 2023 09:02:05 提供 NetDania Notify

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

22 9 2023 09:57:18 提供 NetDania Notify

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

21 9 2023 12:03:54 提供 NetDania Notify

American College of Cardiology Program to Increase Cholesterol Screenings

12 9 2023 09:15:00 提供 Nasdaq GlobeNewswire

Esperion to Participate in H.C. Wainwright 25th Annual Global Investment Conference

28 8 2023 07:00:00 提供 Nasdaq GlobeNewswire

Esperion Presents Two CLEAR Outcomes Study Late-Breakers at European Society of Cardiology Congress 2023

26 8 2023 10:00:00 提供 Nasdaq GlobeNewswire

Two CLEAR Outcomes Study Late-Breakers Accepted at European Society of Cardiology (ESC) Congress 2023

11 8 2023 07:00:00 提供 Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

08 8 2023 15:15:00 提供 Nasdaq GlobeNewswire

Esperion Reports Second Quarter 2023 Financial Results

01 8 2023 05:00:00 提供 Nasdaq GlobeNewswire

Esperion to Report Second Quarter 2023 Financial Results on August 1

17 7 2023 05:00:00 提供 Nasdaq GlobeNewswire

Esperion to Present Additional Data from the CLEAR Outcomes Study on CVD Prevention at the American Society for Preventive Cardiology (ASPC) Congress 2023

07 7 2023 07:00:00 提供 Nasdaq GlobeNewswire

Esperion Announces Submission of Application for Expanded Indication with the European Medicines Agency (EMA) for NILEMDO® (bempedoic acid) Tablet and NUSTENDI® (bempedoic acid and ezetimibe) Tablet

28 6 2023 07:00:01 提供 Nasdaq GlobeNewswire

Esperion Presents Results from CLEAR Outcomes Primary Prevention Analysis at 83rd American Diabetes Association Scientific Sessions

24 6 2023 13:30:00 提供 Nasdaq GlobeNewswire